Rafael Fonseca, MD, discusses frontline multiple myeloma treatment patterns

Rafael Fonseca, MD, discusses maintenance regimens for multiple myelomaПодробнее

Rafael Fonseca discusses MOA and Its Impact on Myeloma TreatmentПодробнее

Pathological optimism: seeking a cure for multiple myeloma | Rafael Fonseca, M.D. | Mayo ClinicПодробнее

Final Thoughts on Modern Treatment of MyelomaПодробнее

MCRT Phoenix 2017: The Basics of Myeloma Genetics by Rafael Fonseca, MDПодробнее

MCRT Phoenix 2017: Determining the Right Therapy Strategy by Rafael Fonseca, MDПодробнее

Real-world treatment patterns & outcomes among patients with triple-class exposed myelomaПодробнее

What is Multiple Myeloma? | Dr. Rafael Fonseca, M.D. | The Patient StoryПодробнее

Strategies for Upfront Therapy in Multiple MyelomaПодробнее

Multiple Myeloma: First Line Treatment & Side Effects | Dr. Rafael Fonseca | The Patient StoryПодробнее

Real world implications of the cost of myeloma treatment: it’s not just the cost of the drugsПодробнее

Uses of MRD in patients with multiple myelomaПодробнее

Next steps in myeloma: quadruplets, immunotherapy, and replacing transplantПодробнее

Multiple Myeloma: Looking Ahead | Dr. Rafael Fonseca (5/5) | The Patient StoryПодробнее

Dr. Fonseca on Pivotal Ongoing Trials in Multiple MyelomaПодробнее

MRD Tests and Applications — Rafael Fonseca, MD | MCRT Webcast August 29 (2/4)Подробнее

Daratumumab in the Treatment Landscape for MMПодробнее

Dr. Fonseca on FDA Approval of Daratumumab Triplets in Multiple MyelomaПодробнее

Is Multiple Myeloma Curable? Rafael Fonseca, M.D., Mayo ClinicПодробнее